An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer
Abstract Background Prostate cancer(PCa) ranks among the most frequently diagnosed malignancies in men. The progression and heterogeneity of tumors pose significant challenges to clinical prognosis and treatment strategies. Recently, extrachromosomal DNA(ecDNA) has emerged as a critical player in ca...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03886-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849767437700956160 |
|---|---|
| author | JiangPing Qiu Jiang Wu Nan Zhou Cong Lai Xin Huang Cheng Liu XiaoQing Yuan Kewei Xu |
| author_facet | JiangPing Qiu Jiang Wu Nan Zhou Cong Lai Xin Huang Cheng Liu XiaoQing Yuan Kewei Xu |
| author_sort | JiangPing Qiu |
| collection | DOAJ |
| description | Abstract Background Prostate cancer(PCa) ranks among the most frequently diagnosed malignancies in men. The progression and heterogeneity of tumors pose significant challenges to clinical prognosis and treatment strategies. Recently, extrachromosomal DNA(ecDNA) has emerged as a critical player in cancer biology, influencing tumor progression, metastasis, and resistance to therapy. Oncogenes and regulatory sequences carried on ecDNA(ecDNA genes) can significantly alter the biological characteristics of tumors and their clinical outcomes. Methods In this study, we obtained ecDNA genes specifically expressed in PCa from the ECGA database. To construct a prognostic risk model for Biochemical Recurrence-Free Survival (BRFS), the two most common types of ecDNA genes which are protein-coding genes and long non-coding RNAs, were analyzed using Cox regression and LASSO regression techniques. Through KEGG/GO pathway enrichment analysis, we identified relevant pathways and analyzed the immune cell infiltration status. Functional assays, such as colony formation, CCK-8, migration, and invasion assays, were employed to assess the cellular functions of a key lncRNA AC016394.2. Results Our analysis identified six key ecDNA lncRNAs(ec-lncRNAs), including the ec-lncRNA AC016394.2, with significant prognostic value in PCa. By employing our risk scoring model, patients were classified into high-risk and low-risk groups, revealing significant differences in their BRFS outcomes. The model demonstrated strong predictive accuracy and clinical relevance. The 1/3/5-year AUC of the model is close to 0.8, which is higher than most common clinical indicators such as Gleason score and TM staging. KEGG and GO pathway enrichment analyses revealed that the high-risk group was predominantly enriched in immune-related pathways. Additionally, immune cell infiltration analysis demonstrated notable differences in the distribution of specific immune cell populations between the high-risk and low-risk groups. Knockdown of AC016394.2 inhibited PCa cell proliferation, migration, and invasion. Conclusions This study presents a novel ecDNA gene-based prognostic risk model for PCa, highlighting the functional importance of ec-lncRNA AC016394.2. These findings offer valuable insights into the biological role of ec-lncRNAs, highlighting their potential as targets for precision oncology and therapeutic intervention. |
| format | Article |
| id | doaj-art-ae3f9ba6f0234a4aba24c68ac4bdf9f6 |
| institution | DOAJ |
| issn | 1475-2867 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Cell International |
| spelling | doaj-art-ae3f9ba6f0234a4aba24c68ac4bdf9f62025-08-20T03:04:11ZengBMCCancer Cell International1475-28672025-07-0125111310.1186/s12935-025-03886-9An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancerJiangPing Qiu0Jiang Wu1Nan Zhou2Cong Lai3Xin Huang4Cheng Liu5XiaoQing Yuan6Kewei Xu7Guangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityResearch Center, The Affiliated Brain Hospital, Guangzhou Medical UniversityDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Urology, Ganzhou People’s HospitalDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityAbstract Background Prostate cancer(PCa) ranks among the most frequently diagnosed malignancies in men. The progression and heterogeneity of tumors pose significant challenges to clinical prognosis and treatment strategies. Recently, extrachromosomal DNA(ecDNA) has emerged as a critical player in cancer biology, influencing tumor progression, metastasis, and resistance to therapy. Oncogenes and regulatory sequences carried on ecDNA(ecDNA genes) can significantly alter the biological characteristics of tumors and their clinical outcomes. Methods In this study, we obtained ecDNA genes specifically expressed in PCa from the ECGA database. To construct a prognostic risk model for Biochemical Recurrence-Free Survival (BRFS), the two most common types of ecDNA genes which are protein-coding genes and long non-coding RNAs, were analyzed using Cox regression and LASSO regression techniques. Through KEGG/GO pathway enrichment analysis, we identified relevant pathways and analyzed the immune cell infiltration status. Functional assays, such as colony formation, CCK-8, migration, and invasion assays, were employed to assess the cellular functions of a key lncRNA AC016394.2. Results Our analysis identified six key ecDNA lncRNAs(ec-lncRNAs), including the ec-lncRNA AC016394.2, with significant prognostic value in PCa. By employing our risk scoring model, patients were classified into high-risk and low-risk groups, revealing significant differences in their BRFS outcomes. The model demonstrated strong predictive accuracy and clinical relevance. The 1/3/5-year AUC of the model is close to 0.8, which is higher than most common clinical indicators such as Gleason score and TM staging. KEGG and GO pathway enrichment analyses revealed that the high-risk group was predominantly enriched in immune-related pathways. Additionally, immune cell infiltration analysis demonstrated notable differences in the distribution of specific immune cell populations between the high-risk and low-risk groups. Knockdown of AC016394.2 inhibited PCa cell proliferation, migration, and invasion. Conclusions This study presents a novel ecDNA gene-based prognostic risk model for PCa, highlighting the functional importance of ec-lncRNA AC016394.2. These findings offer valuable insights into the biological role of ec-lncRNAs, highlighting their potential as targets for precision oncology and therapeutic intervention.https://doi.org/10.1186/s12935-025-03886-9EcDNA geneTCGAProstate cancerPrognostic modelAC016394.2 |
| spellingShingle | JiangPing Qiu Jiang Wu Nan Zhou Cong Lai Xin Huang Cheng Liu XiaoQing Yuan Kewei Xu An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer Cancer Cell International EcDNA gene TCGA Prostate cancer Prognostic model AC016394.2 |
| title | An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer |
| title_full | An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer |
| title_fullStr | An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer |
| title_full_unstemmed | An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer |
| title_short | An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer |
| title_sort | ecdna gene based risk model and functional verification of a key ec lncrna ac016394 2 for prostate cancer |
| topic | EcDNA gene TCGA Prostate cancer Prognostic model AC016394.2 |
| url | https://doi.org/10.1186/s12935-025-03886-9 |
| work_keys_str_mv | AT jiangpingqiu anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT jiangwu anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT nanzhou anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT conglai anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT xinhuang anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT chengliu anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT xiaoqingyuan anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT keweixu anecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT jiangpingqiu ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT jiangwu ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT nanzhou ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT conglai ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT xinhuang ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT chengliu ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT xiaoqingyuan ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer AT keweixu ecdnagenebasedriskmodelandfunctionalverificationofakeyeclncrnaac0163942forprostatecancer |